Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Total Assets
\$768.55 Mil (As of Mar. 2015)

Synageva BioPharma Corp's total assets for the quarter that ended in Mar. 2015 was \$768.55 Mil.

Total Assets is connected with Return on Assets (ROA). Synageva BioPharma Corp's annualized Return on Assets (ROA) for the quarter that ended in Mar. 2015 was -37.46%. Total Assets is also linked to revenue through asset turnover. Synageva BioPharma Corp's asset turnover for the quarter that ended in Mar. 2015 was 0.00.

Definition

Total assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholders paid in capital and retained earnings of the business. Others are funded through borrowed money.

Synageva BioPharma Corp's Total Assets for the fiscal year that ended in Dec. 2014 is calculated as

 Total Assets = Total Current Assets + Total Long Term Assets = Total Current Assets + (Net PPE + Intangibles + Other Long-Term Assets) = 457.832 + (31.559 + 10.538 + 2.274) = 502.20

 Total Assets = Total Shareholders Equity (A: Dec. 2014 ) + Total Liabilities (A: Dec. 2014 ) = 473.239 + 30.964 = 504.20

Synageva BioPharma Corp's Total Assets for the quarter that ended in Mar. 2015 is calculated as

 Total Assets = Total Current Assets + Total Long Term Assets = Total Current Assets + (Net PPE + Intangibles + Other Long-Term Assets) = 722.278 + (31.917 + 10.316 + 2.291) = 766.80

 Total Assets = Total Shareholders Equity (Q: Mar. 2015 ) + Total Liabilities (Q: Mar. 2015 ) = 735.126 + 33.42 = 768.55

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

Total Assets is connected with Return on Assets.

Synageva BioPharma Corp's annualized Return on Assets (ROA) for the quarter that ended in Mar. 2015 is

 ROA = Net Income (Q: Mar. 2015 ) / ( (Total Assets (Q: Dec. 2014 ) + Total Assets (Q: Mar. 2015 )) / 2 ) = -238.404 / ( (504.203 + 768.546) / 2 ) = -238.404 / 636.3745 = -37.46 %

Note: The Net Income data used here is four times the quarterly (Mar. 2015) net income data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Synageva BioPharma Corp's Asset Turnover for the quarter that ended in Mar. 2015 is

 Asset Turnover = Sales / Average Total Assets = Revenue (Q: Mar. 2015 ) / ( (Total Assets (Q: Dec. 2014 ) + Total Assets (Q: Mar. 2015 )) / 2 ) = 0.927 / ( (504.203 + 768.546) / 2 ) = 0.927 / 636.3745 = 0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Therefore, if a company grows its assets faster than its sales, the asset turnover will decline. This might be a warning sign for the business.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Total Assets 60.14 74.90 94.12 44.21 60.26 16.98 83.30 243.26 447.95 504.20

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Total Assets 243.26 341.15 324.19 471.88 447.95 623.10 593.24 548.21 504.20 768.55
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)